Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-367,146
Closed -$89.2M 121
2018
Q2
$89.2M Buy
367,146
+138,324
+60% +$34.4M 1.4% 20
2018
Q1
$51.1M Sell
228,822
-158,224
-41% -$39M 1.04% 39
2017
Q4
$90.7M Buy
+387,046
New +$94.6M 2.15% 10
2015
Q3
Sell
-300,799
Closed -$59.9M 79
2015
Q2
$59.9M Buy
+300,799
New +$61.6M 1.52% 25
2015
Q1
Sell
-146,036
Closed -$33.3M 88
2014
Q4
$33.3M Sell
146,036
-536,431
-79% -$123M 0.78% 44
2014
Q3
$149M Buy
682,467
+447,733
+191% +$94.7M 3.43% 8
2014
Q2
$43.9M Buy
+234,734
New +$38.4M 0.88% 37
2014
Q1
Sell
-342,395
Closed -$60.9M 76
2013
Q4
$60.9M Sell
342,395
-368,004
-52% -$59.5M 1.22% 30
2013
Q3
$110M Buy
+710,399
New +$91.6M 2.66% 13

Other funds holding BIDU

PFM Health Sciences's BIDU Position: Q3 2018 in Review

PFM Health Sciences sold out of Baidu (BIDU) in Q3 2018, closing a stake of 367,146 shares — an estimated $89.2M sold.

PFM Health Sciences first reported a position in BIDU in Q3 2013 and held it in 9 quarters. The position peaked at $149M in Q3 2014. 804 funds tracked by Wall St. Rank hold BIDU as of Q3 2018.

  • PFM Health Sciences reported no remaining Baidu position as of Q3 2018 after selling out during the quarter.
  • PFM Health Sciences sold 367,146 Baidu shares in Q3 2018, an estimated $89.2M.
  • PFM Health Sciences first reported a position in Baidu in Q3 2013 and held it in 9 quarters.
  • PFM Health Sciences's Baidu position peaked at $149M in Q3 2014.
  • 804 funds tracked by Wall St. Rank held Baidu as of Q3 2018.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.